ONDANSETRON (GR38032F) PLUS DEXAMETHASONE - EFFECTIVE ANTIEMETIC PROPHYLAXIS FOR PATIENTS RECEIVING CYTOTOXIC CHEMOTHERAPY

被引：49
|
作者：
SMITH, DB
NEWLANDS, ES
SPRUYT, OW
BEGENT, RHJ
RUSTIN, GJS
MELLOR, B
BAGSHAWE, KD
机构：
[1] Cancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross Hospital, London
来源：
BRITISH JOURNAL OF CANCER | 1990年 / 61卷 / 02期
关键词：
D O I：
10.1038/bjc.1990.62
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：323 / 324
页数：2
相关论文
共 50 条
  • [21] CISPLATIN-INDUCED CONDITIONED TASTE-AVERSION - ATTENUATION BY DEXAMETHASONE BUT NOT ZACOPRIDE OR GR38032F
    MELE, PC
    MCDONOUGH, JR
    MCLEAN, DB
    OHALLORAN, KP
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 218 (2-3) : 229 - 236
  • [22] ONDANSETRON - A NEW ANTIEMETIC FOR PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY
    EINHORN, LH
    NAGY, C
    WERNER, K
    FINN, AL
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) : 731 - 735
  • [23] A comparison of dexamethasone, ondansetron, and dexamethasone plus ondansetron as prophylactic antiemetic and antipruritic therapy in patients receiving intrathecal morphine for major orthopedic surgery
    Szarvas, S
    Chellapuri, RS
    Harmon, DC
    Owens, J
    Murphy, D
    Shorten, GD
    ANESTHESIA AND ANALGESIA, 2003, 97 (01): : 259 - 263
  • [24] A PHASE-I-II STUDY OF THE 5-HT3 ANTAGONIST GR38032F IN THE ANTI-EMETIC PROPHYLAXIS OF PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY
    SMITH, DB
    NEWLANDS, ES
    RUSTIN, GJS
    BEGENT, RHJ
    CRAWFORD, SM
    BAGSHAWE, KD
    CARRUTHERS, L
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (04) : 291 - 294
  • [25] COLONIC TRANSIT IN MAN IS SLOWED BY ONDANSETRON (GR38032F), A SELECTIVE 5-HYDROXYTRYPTAMINE RECEPTOR (TYPE-3) ANTAGONIST
    GORE, S
    GILMORE, IT
    HAIGH, CG
    BROWNLESS, SM
    STOCKDALE, H
    MORRIS, AI
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1990, 4 (02) : 139 - 144
  • [26] ANTIEMETIC ACTIVITY OF ONDANSETRON IN CANCER-PATIENTS RECEIVING NONCISPLATIN CHEMOTHERAPY
    FRASCHINI, G
    SEMINARS IN ONCOLOGY, 1992, 19 (04) : 41 - 47
  • [27] AN OPEN STUDY OF ONDANSETRON (O) AS ANTIEMETIC IN PATIENTS FAILING USUAL ANTIEMETIC THERAPY FOR CYTOTOXIC CHEMOTHERAPY
    ALLAN, SG
    FORGESON, GV
    HUMM, G
    LANGLEY, G
    NEW ZEALAND MEDICAL JOURNAL, 1991, 104 (913) : 234 - 234
  • [28] GR38032F, A 5HT3 RECEPTOR ANTAGONIST, IN THE PROPHYLAXIS OF ACUTE CISPLATIN-INDUCED NAUSEA AND VOMITING
    MARTY, M
    DROZ, JP
    POUILLART, P
    PAULE, B
    BRION, N
    BONS, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (06) : 389 - 391
  • [29] Dexamethasone versus a combination of dexamethasone and ondansetron as prophylactic antiemetic in patients receiving intrathecal morphine for caesarean section
    Imeh, Akpan
    Olaniyi, Oladapo
    Simeon, Olateju
    Omotola, Odusoga
    AFRICAN HEALTH SCIENCES, 2014, 14 (02) : 453 - 459
  • [30] An analysis of the antiemetic protection of metoclopramide plus dexamethasone in Chinese patients receiving moderately high emetogenic chemotherapy
    Molassiotis, A
    Mok, TSK
    Yam, BMC
    Yung, H
    EUROPEAN JOURNAL OF CANCER CARE, 2002, 11 (02) : 108 - 113
12345